Exploring the Evolving Role of HER2 for the Treatment of Gynecologic Cancers
Webinar/Online
Thursday, April 17, 2025 at 2:00pm ET - 2:30pm ET
Add this event to your calendar
Info
Topic
The role of HER2 in gynecologic cancers is evolving-are you up to speed? Don't miss this live, expert-led session where we will dive into guideline-aligned strategies for HER2 testing, the latest clinical evidence, and personalized treatment planning. Gain important insights, including: The prevalence and relevance of HER2 overexpression in ovarian, endometrial, and cervical cancers Best practices for HER2 testing to ensure accurate identification of patients with HER2 overexpressing tumors The latest clinical data on HER2-directed therapies and their impact on personalized treatment. Stay ahead of the latest advancements and bring back valuable insights to your clinical practice!
Credits Offered
This event offers
0.5 contact hours
to attendees.
Accreditation Info:
AANP.
Additional Information
The role of HER2 in gynecologic cancers is evolving-are you up to speed? Don't miss this live, expert-led session where we will dive into guideline-aligned strategies for HER2 testing, the latest clinical evidence, and personalized treatment planning
Speakers
Associate Professor of Pathology and Laboratory Medicine
Robert Larner, MD College of Medicine
University of Vermont
Medical Director, Genomic Medicine
University of Vermont Medical Center
Burlington, VT
Medical Oncologist
Division of Gynecologic Oncology & Center for Cancer Therapeutic Innovation
Dana-Farber Cancer Institute
Boston, Massachusetts
Vice President, Payer Contracting
Amber Specialty Pharmacy